These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2428327)

  • 1. Tricyclic antidepressant washout effects on cerebrospinal fluid and urinary monoamine and metabolites.
    Koslow SH; Maas JW; Bowden CL; Davis JM; Hanin I; Javaid J
    Arch Gen Psychiatry; 1986 Oct; 43(10):1012-3. PubMed ID: 2428327
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls.
    Davis JM; Koslow SH; Gibbons RD; Maas JW; Bowden CL; Casper R; Hanin I; Javaid JI; Chang SS; Stokes PE
    Arch Gen Psychiatry; 1988 Aug; 45(8):705-17. PubMed ID: 2456047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
    Maas JW; Koslow SH; Katz MM; Bowden CL; Gibbons RL; Stokes PE; Robins E; Davis JM
    Am J Psychiatry; 1984 Oct; 141(10):1159-71. PubMed ID: 6207736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of cerebrospinal fluid monoamine metabolites in suicides.
    Lester D
    Psychol Rep; 1991 Feb; 68(1):146. PubMed ID: 1709746
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes of cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment.
    Bäckman J; Alling C; Alsén M; Regnéll G; Träskman-Bendz L
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):341-9. PubMed ID: 10974605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
    Goodwin FK; Post RM
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():299-332. PubMed ID: 769117
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in rat brain monoamine turnover following chronic antidepressant administration.
    Sugrue MF
    Life Sci; 1980 Feb; 26(6):423-9. PubMed ID: 6154860
    [No Abstract]   [Full Text] [Related]  

  • 8. Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity.
    Stokes PE; Maas JW; Davis JM; Koslow SH; Casper RC; Stoll PM
    Am J Psychiatry; 1987 Jul; 144(7):868-72. PubMed ID: 2440319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report.
    Bryer JB; Starkstein SE; Votypka V; Parikh RM; Price TR; Robinson RG
    J Neuropsychiatry Clin Neurosci; 1992; 4(4):440-2. PubMed ID: 1384852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF monoamine metabolites, depression, and suicide.
    Asberg M; Bertilsson L; Mårtensson B
    Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoamine neurotransmitter interactions and the prediction of antidepressant response.
    Hsiao JK; Agren H; Bartko JJ; Rudorfer MV; Linnoila M; Potter WZ
    Arch Gen Psychiatry; 1987 Dec; 44(12):1078-83. PubMed ID: 2446588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrections to a 1980 article on CSF monoamine metabolites.
    Faull KF; Berger PA; Kilkowski J; Anderson PJ; Kraemer H; Davis KL; Barchas JD
    Am J Psychiatry; 1989 Jan; 146(1):118. PubMed ID: 2463774
    [No Abstract]   [Full Text] [Related]  

  • 13. Seasonal changes of CSF monoamine metabolites in psychiatric patients: what is the source?
    Csernansky JG; Faull KF; Pfefferbaum A
    Psychiatry Res; 1988 Sep; 25(3):361-3. PubMed ID: 2460883
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
    Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of chronic alprazolam on sleep and bioamine metabolites in depression.
    Zarcone VP; Benson KL; Greene KA; Csernansky JG; Faull KF
    J Clin Psychopharmacol; 1994 Feb; 14(1):36-40. PubMed ID: 7512100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of suicidal behavior from biologic tests.
    Träskman-Bendz L; Alling C; Oreland L; Regnéll G; Vinge E; Ohman R
    J Clin Psychopharmacol; 1992 Apr; 12(2 Suppl):21S-26S. PubMed ID: 1374434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isocratic analysis of 3-methoxy-4-hydroxyphenyl glycol, 5-hydroxyindole-3-acetic acid and 4-hydroxy-3-methoxyphenylacetic acid in cerebrospinal fluid by high-performance liquid chromatography with amperometric detection.
    Bottiglieri T; Lim CK; Peters TJ
    J Chromatogr; 1984 Nov; 311(2):354-60. PubMed ID: 6084013
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoamine metabolites as predictors of antidepressant response: a critique.
    Kelwala S; Jones D; Sitaram N
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):229-40. PubMed ID: 6193563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biogenic amines in seasonal affective disorder: effects of light therapy.
    Rudorfer MV; Skwerer RG; Rosenthal NE
    Psychiatry Res; 1993 Jan; 46(1):19-28. PubMed ID: 7681996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.